Helicobacter pylori are a stomach infection mostly affecting the upper part of the small intestine (duodenum). Over recent years, the burden of the infection across the world is growing continually. Fortunately, there are novel diagnostic tests available to detect the infection. These tests are called H. Pylori (Helicobacter Pylori) Tests. Rising prevalence of H. pylori infection and the growing adoption of these tests for its diagnosis are major growth drivers of the market.
Helicobacter Pylori Test Market is expected to hold a value of USD 2,924.2 Million by 2025 at a CAGR of 5.2%.
Also, factors such as the contaminated water or food, the rapidly growing global population, poor sanitation practices, neglected personal hygiene, and rising cases of dyspepsia globally, act as key tailwinds pushing the market growth. Besides, the growing awareness among individuals for H. pylori infection and its tests, propel the market demand. However, there is a large scope for the development of more H. Pylori tests and treatments. The absence of definitive treatment procedures for the infection is becoming a paramount concern.
- Pylori (Helicobacter Pylori) Test Market – Segments
The report is segmented into four dynamics.
By Test Type: Non-Endoscopic and Endoscopic.
By Technology: Immunoassays, Point-of-Care (POC), Molecular Diagnostics, and others.
By End-User: Hospitals Clinics, Diagnostics Laboratories, and others.
By Regions: Americas, Europe, Asia Pacific, and the Rest-of-the-World.
Helicobacter Pylori Test Market – Regional Analysis
North America dominates the global H. Pylori test market. The largest market share attributes well-developed healthcare sectors and a huge patient population. Besides, the rising numbers of diagnostic companies in the region impact the growth of helicobacter pylori market in North America. Additionally, increasing numbers of clinical research led by funding from the public private organizations are fostering the H. Pylori test market in the region.
Moreover, the strong presence of major diagnostic companies such as Bio-Rad Laboratories, Thermo Fisher Scientific Inc., Inc., Abbott Laboratories, and Quest Diagnostics Incorporated, Cardinal Health, enables early adoption of advanced diagnostic products. Also, the changing lifestyle and high per capita healthcare expenditure of demographics are fuelling the growth of the regional market. The North American helicobacter pylori market is estimated to retain its leading position in the global market throughout the review period.
The Asia pacific helicobacter pylori test market is growing rapidly. Factors such as increasing advances in medical technologies and the fast-growing healthcare sector in the region are propelling the growth of the market. Also, growing government support for RD boosts the growth H. Pylori Test market in the region. Besides, the continually rising population and poor sanitation conditions, alongside the rising burden of the H. pylori infection in the region, drive the market growth.
- Pylori Test Market – Competitive Analysis
Highly competitive, the H. Pylori Test market appears fragmented due to the presence of several well-established players. To gain a larger competitive share, these players incorporate strategies such as mergers acquisitions, collaboration, expansion, and product launch. Players invest substantially in RD and clinical trials to develop tests that can give an accurate diagnosis of the infection.
They increase RD to develop breakthrough drugs and therapeutic approaches that can improve patients' quality of life. Companies also focus on areas with high unmet medical needs and require further innovation despite the progress that has been made.
Major Players:
Key players leading the global H. Pylori Test market include Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), Hoffmann-La Roche Ltd (Switzerland), Quest Diagnostics Incorporated (US), Meridian Bioscience (US), CorisBioconcept SPRL (Belgium), Cardinal Health (US), QIAGEN (Germany), Abbott Laboratories (US), and Biohit Oyj (Finland), among others.
